**Author details**

Stephen Rathinaraj Benjamin1 \* and Fabio de Lima2

1 Department of Biomedical Engineering, Federal University of Pernambuco, Recife, PE, Brazil

2 Department of Computer Science, Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil

\*Address all correspondence to: biotechstephen@gmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**103**

*Current and Prospective of Breast Cancer Biomarkers DOI: http://dx.doi.org/10.5772/intechopen.91151*

[1] WHO. WHO Cancer Fact Sheet 2018. 2018. Available from: https://www. who.int/news-room/fact-sheets/detail/

[9] De Oliveira RAG, Materon EM, Melendez ME, Carvalho AL, Faria RC. Disposable microfluidic immunoarray device for sensitive breast cancer biomarker detection. ACS Applied Materials and Interfaces.

[10] Qin D, Jiang X, Mo G, Feng J, Yu C, Deng B. A novel carbon quantum dots signal amplification strategy coupled with sandwich electrochemiluminescence immunosensor for the detection of ca15-3 in human serum. ACS Sensors.

[11] Wang A-J, Zhu X-Y, Chen Y, Luo X, Xue Y, Feng J-J. Ultrasensitive labelfree electrochemical immunoassay of carbohydrate antigen 15-3 using dendritic Au@Pt nanocrystals/ferrocenegrafted-chitosan for efficient signal amplification. Sensors and Actuators, B:

[12] Khoshroo A, Mazloum-Ardakani M, Forat-Yazdi M. Enhanced performance

immunosensor for carbohydrate antigen 15-3 based on catalytic activity of cobalt sulfide/graphene nanocomposite. Sensors and Actuators, B: Chemical.

[13] WHO. Press announcements—FDA approves new treatment for certain advanced or metastatic breast cancers.

Chemical. 2019;**292**:164-170

of label-free electrochemical

2018;**255**:580-587

2014;**4**(105):1-8

2018;**106**:78-85

FDA News Release. 2017

[14] Olsen D, Trøst Jørgensen J. Companion diagnostics for targeted cancer drugs—Clinical and regulatory

aspects. Frontiers in Oncology.

[15] Sharma S, Zapatero-Rodríguez J, Saxena R, O'Kennedy R, Srivastava S. Ultrasensitive direct impedimetric immunosensor for detection of serum HER2. Biosensors and Bioelectronics.

2017;**9**(33):27433-27440

2019;**4**(2):504-512

[2] WHO. WHO Breast cancer. WHO. 2017. Available from: https:// www.who.int/cancer/prevention/ diagnosis-screening/breast-cancer/en/

[3] Wei PL, Lee LT, Tseng LM, Huang KW. Validation of assaying carcinoembryonic antigen in human serum by using immunomagnetic reduction. Scientific Reports.

[4] Rizwan M, Elma S, Lim SA, Ahmed MU. AuNPs/CNOs/SWCNTs/ chitosan-nanocomposite modified electrochemical sensor for the labelfree detection of carcinoembryonic antigen. Biosensors and Bioelectronics.

[5] Gao Y-S, Zhu X-F, Xu J-K, Lu L-M, Wang W-M, Yang T-T, et al. Label-free electrochemical immunosensor based on Nile blue A-reduced graphene oxide nanocomposites for carcinoembryonic

antigen detection. Analytical Biochemistry. 2016;**500**:80-87

[6] Lu W, Cao X, Tao L, Ge J, Dong J, Qian W. A novel label-free amperometric immunosensor for carcinoembryonic antigen based on Ag nanoparticle decorated infinite coordination polymer fibres. Biosensors and Bioelectronics.

[7] Li H, Qin J, Li M, Li C, Xu S, Qian L, et al. Gold-nanoparticle-decorated boron-doped graphene/BDD electrode for tumor marker sensor. Sensors and Actuators, B: Chemical. 2020;**302**:127209

[8] DeSantis C, Naishadham D, Jemal A. Cancer statistics for African Americans,

2013. CA: A Cancer Journal for Clinicians. 2013;**63**(3):151-166

2018;**8**(1):10002

2018;**107**:211-217

2014;**57**:219-225

cancer

**References**

*Current and Prospective of Breast Cancer Biomarkers DOI: http://dx.doi.org/10.5772/intechopen.91151*
